Capriotti, Kara D.
Anadkat, Milan
Choi, Jennifer
Kaffenberger, Benjamin
McLellan, Beth
Barone, Samuel
Kukoyi, Oluwaseun
Goldfarb, Shari
Lacouture, Mario
Funding for this research was provided by:
Veloce Biopharma
NIH/NCI Cancer Center Support Grant (P30 CA008748)
Dermatology Foundation Career Development Award
Article History
Received: 16 May 2019
Accepted: 19 June 2019
First Online: 26 June 2019
Compliance with ethical standards
:
: K. Capriotti owns equity and is an employee of Veloce BioPharma. M. Anadkat has received honoraria for consulting and/or speaking engagements in the past from Adgero, Astra Zeneca, Boehringer-Ingelheim, Bristol Myers Squibb, Biogen, Eli Lilly, Genentech, ImClone, Therakos, Xoma, and Eisai and has also served as a Principal Investigator for Biogen, Veloce BioPharma, Xoma, Hana Biosciences, and InflamRx. J. Choi declares that she has no conflict of interest. B. Kaffenberger is an Investigator for Biogen, Celgene, Eli Lilly Co, and Veloce BioPharma. B. McLellan has served as an investigator for Veloce BioPharma. S. Barone owns equity and is an employee of Veloce BioPharma. All other authors have declared no relevant conflicts of interest. O. Kukoyi declares that he has no conflict of interest. S. Goldfarb declares that she has no conflict of interest. M. Lacouture has a consultant/speaking role with Legacy Healthcare Services, Adgero Bio Pharmaceuticals, Amryt Pharmaceuticals, Celldex Therapeutics, Debiopharm, Galderma Research and Development, Johnson and Johnson, Novocure Inc., Lindi, Merck Sharp and Dohme Corporation, Helsinn Healthcare SA, Janssen Research & Development LLC, Menlo Therapeutics, Novartis Pharmaceuticals Corporation, F. Hoffmann-La Roche AG, AbbVie Inc., Boehringer Ingelheim Pharma Gmbh & Co. KG, Allergan Inc., Amgen Inc., E.R. Squibb & Sons LLC, EMD Serono Inc., AstraZeneca Pharmaceuticals LP, Genentech Inc., Leo Pharma Inc., Seattle Genetics, Bayer, Manner SAS, Lutris, Pierre Fabre, Paxman Coolers, Adjucare, Dignitana, Biotechspert, Teva Mexico, Parexel, OnQuality Pharmaceuticals Ltd., Oncoderm, Apricity, Novartis, and Our Brain Bank. Dr. Lacouture also receives research funding from Berg, Bristol-Myers Squibb, Lutris, Paxman, Novocure, US Biotest, and Veloce BioPharma.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.